Diagnostic Approach to Hyperinsulinemic Hypoglycemia with Elevated Liver Enzymes

Diagnostic Criteria

The combination of hyperinsulinemia, elevated C-peptide, normal fasting glucose, and markedly elevated transaminases in a child points strongly toward a glycogen storage disease rather than primary hyperinsulinism 1, 2
Morning symptoms, such as tachycardia and dizziness, represent counter-regulatory responses to nocturnal hypoglycemia and are pathognomonic for disorders of glucose homeostasis 1, 3
Elevated transaminases with normal glucose are characteristic of GSD Type III, where transaminases are often 2-3 times upper limits of normal 3, 4

Fasting metabolic panel should measure lactate, uric acid, cholesterol, triglycerides, and beta-hydroxybutyrate during a supervised brief fast 1, 3, 4
Genetic testing, including full sequencing of G6PC, SLC37A4, and AGL genes, should be performed immediately to confirm diagnosis 1, 2, 3

Immediate dietary intervention is essential to prevent hypoglycemia, lactic acidosis, and potential seizures, permanent brain damage, or death 1, 2
For GSD Type I, frequent feedings with small, frequent meals high in complex carbohydrates and overnight management with continuous gastric feedings or cornstarch supplementation are recommended 1, 2
For GSD Type III, a high-protein diet and overnight support with bedtime snack or continuous enteral feeding may be necessary 7

Regular ultrasound surveillance every 6-12 months is necessary to monitor for hepatic adenomas, which occur in 16-75% of GSD patients 6
Hepatocellular carcinoma risk should be screened with ultrasound and alpha-fetoprotein, though AFP may remain normal in GSD III 6, 7
Cardiac and muscle monitoring, including regular echocardiograms and CK monitoring, are needed for GSD Type IIIa to detect cardiomyopathy and progressive myopathy 3, 4